MBE Advance Access published online on January 22, 2004
Molecular Biology and Evolution, doi:10.1093/molbev/msh053
Molecular Biology and Evolution © Society for Molecular Biology and Evolution 2004; all rights reserved
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium
* To whom correspondence should be addressed. E-mail: Sonia.VanDooren{at}uz.kuleuven.ac.be.
The evolutionary rate of the Human T-Cell Lymphotropic Virus Type-1 (HTLV-1) is considered to be very low, in strong contrast to the related human retrovirus HIV. However, current estimates of the HTLV-1 rate rely on the anthropological calibration of phylogenies using assumed dates of human migration events. To obtain an independent rate estimate, we analysed two variable regions of the HTLV-1 genome (LTR and env) from 8 infected families. Remarkable genetic stability was observed, as only 2 mutations in LTR (756bp) and 3 mutations in env (522bp) occurred within the 16 vertical transmission chains, including one ambiguous position in each region. The evolutionary rate in HTLV-1 was then calculated using a maximum likelihood approach that used the highest and lowest possible times of HTLV-1 shared ancestry, given the known transmission histories. The rates for the LTR and env regions were 9.58*10-8-1.25*10-5 and 7.84*10-7-2.33*10-5 nucleotide substitutions per site per year, respectively. A more precise estimate was obtained for the combined LTR-env data set, which was 7.06*10-7-1.38*10-5 substitutions per site per year. We also note an interesting correlation between the occurrence of mutations in HTLV-1 and the age of the individual infected. Key Words:
HTLV-1, vertical transmission, evolutionary rate, molecular clock
© 2004 Society for Molecular Biology and Evolution
Original Articles
The Low Evolutionary Rate of Human T-Cell Lymphotropic Virus Type-1 Confirmed by Analysis of Vertical Transmission Chains
2 Department of Zoology, University of Oxford, South Parks Road, Oxford, OX1 3PS, UK
3 Department. of Medical Research, Mackay Memorial Hospital, Min-Sheng Road 45, Taipei- Tamshui 251, Taiwan
4 Université Catholique de Louvain, Unité de Virologie, 1200 Bruxelles, Belgium
5 Hospital San Roque, San Salvador de Jujuy, Argentina
6 Laboratoire de Rétrovirologie, Institut Pasteur de la Guyane, BP6010, 23 Av. Pasteur, 97300 Cayenne, French Guiana
7 Instituto de Medicina Tropical 'Alexander Von Humboldt', Universidad Peruana Cayetano Heredia, Lima, Peru
8 Gonçalo Moniz Research Center, Oswaldo Cruz Foundation, Bahia School of Medicine and Public Health, Salvador, Bahia, Brazil
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. M. Coffin and J. P. Stoye A New Virus for Old Diseases? Science, October 23, 2009; 326(5952): 530 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Calvignac, J.-M. Terme, S. M. Hensley, P. Jalinot, A. D. Greenwood, and C. Hanni Ancient DNA Identification of Early 20th Century Simian T-Cell Leukemia Virus Type 1 Mol. Biol. Evol., June 1, 2008; 25(6): 1093 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Focosi, M. Petrini, H. Tamaki, and M. Matsuoka More on donor-derived T-cell leukemia after bone marrow transplantation. N. Engl. J. Med., July 13, 2006; 355(2): 212 - 213. [Full Text] [PDF] |
||||


